Skip to main content
Cancer Explained
Donate
Beginner 5 min readSource checked

When Melanoma Comes Back: Recurrence Questions

What to ask when melanoma may have returned, including biopsy, biomarkers, treatment goals, and second opinions.

This is general education — it cannot tell you what to do in your situation.

Instructions and urgent-contact thresholds vary by treatment and care team. If you are in treatment, follow the instructions your oncology team gave you, and contact them about any new or worsening symptom. If you think you may be having a medical emergency, call your local emergency number.

NCI source

NCI PDQ — Melanoma Treatment (Patient Version)

Four adults with daypacks walk a dirt trail through green coastal hills, talking and smiling.
Hiking With Friends

Key fact

NCI says recurrent melanoma may return where it started or elsewhere in the body, such as the lungs or liver.

The short answer

Melanoma comes back at or near the scar, in transit between the scar and the nearest nodes, or in nodes and distant organs. NCI says it may return where it started or elsewhere, such as the lungs or liver. The node surgery question has changed, and the treatment list now runs on immunotherapy and BRAF-directed targeted therapy.

  • NCI says recurrent melanoma may return where it started or elsewhere in the body, such as the lungs or liver.

  • In-transit disease, in the skin between the scar and the nearest node basin, is a pattern melanoma produces more than most cancers.

  • Routine complete node dissection after a positive sentinel node is no longer automatic: in the trial NCI reports it did not improve distant metastasis-free survival and lymphedema occurred in 24.1% versus 6.3%.

  • NCI's list for unresectable stage III, stage IV and recurrent melanoma runs on immunotherapy and on BRAF and MEK targeted drugs; the list is a catalogue rather than a ranking, and includes older agents now used in narrow circumstances.

Choose how you want to understand this

The full explanation.

The three places melanoma comes back

NCI says recurrent melanoma may return where it started, or elsewhere in the body, such as the lungs or liver.

In practice teams talk about three patterns. A return at or near the scar. In-transit disease, meaning deposits in the skin and tissue between the scar and the nearest node basin. And spread to lymph nodes or distant organs.

In-transit disease gets a lot of attention in melanoma. It is a pattern this cancer produces more than most.

Your own eyes are part of the surveillance

NCI's diagnostic list starts with a skin exam, where a doctor or nurse checks the skin for areas that look wrong in color, size, shape or texture.

That same exam is what you can partly do yourself, monthly, between visits. Ask to be shown how.

Ask what you are feeling for along the path between the scar and the nodes.

The node question that changed

If a sentinel node contains melanoma, removing all the nodes in that area used to be routine. The evidence moved.

NCI reports a trial where complete node dissection did not improve distant metastasis-free survival. Lymphedema occurred in 24.1% of the dissection group, against 6.3% of the group under observation.

NCI describes ultrasound surveillance of the regional nodes as an option for people with hidden node disease. Ask whether that applies to you.

What treatment looks like now

For stage III melanoma that cannot be removed, stage IV, and recurrent melanoma, NCI lists immunotherapy with pembrolizumab, nivolumab, ipilimumab, interleukin-2, nivolumab with relatlimab, or atezolizumab. A catalogue is not a running order. Interleukin-2 comes from an earlier era and is now used rarely, in selected centres. What your team proposes will turn on your BRAF result, whether you already had adjuvant immunotherapy, how fast the disease is moving, and what your body can tolerate.

Targeted therapy is the other track. NCI names dabrafenib, trametinib, vemurafenib, cobimetinib, encorafenib and binimetinib.

For melanoma in a limb, isolated limb perfusion and injected talimogene laherparepvec both appear in NCI's summaries.

Questions for the melanoma team

  • Is this at the scar, in transit, in the nodes, or further away?
  • Do I need a biopsy of the new spot to confirm it is melanoma?
  • Has my tumor been tested for a BRAF change, and does that open the targeted track?
  • What is my LDH level, and what does it tell you here?
  • I had adjuvant pembrolizumab or nivolumab already. Does that change which drug you would use now?
  • These spots are on my leg. Would injected therapy or limb perfusion be considered?
  • How often will you check my skin and nodes from here?

When another melanoma specialist should look

Melanoma treatment has changed fast. NCI itself notes that new drugs and combinations are arriving quickly, and suggests considering a clinical trial at progression.

That is a good reason to get a second opinion, especially at a center that runs melanoma trials.

When to get help sooner

  • Call 911 or go to an emergency department if you have a seizure, sudden weakness or numbness on one side, sudden trouble speaking or seeing, or the worst headache of your life with vomiting. Melanoma spreads to the brain more often than most cancers, and these are the signs of that. Go too for severe breathlessness or chest pain.
  • Call your care team the same day if you are on pembrolizumab or nivolumab and have several watery stools a day, blood or mucus in your stool, a new cough or breathlessness, yellow eyes or dark urine, or a rash that is blistering or peeling. These drugs can turn the immune system against healthy organs. Getting assessed early matters, because your team has to sort an immune side effect from an infection before deciding what to do; steroids are one of the treatments they may use, not an automatic one. Use the 24-hour number on your immunotherapy card, and carry the card. Call for a temperature of 100.4°F (38°C) or higher too.
  • Call your care team within a day or two if a new lump appears at or near your old scar, you feel a firm nodule under the skin between the scar and the nearest nodes, or a lymph node stays swollen. Do the same for unusual tiredness, dizziness, or feeling cold all the time, which can point to a hormone gland affected by immunotherapy.

See also: Local vs Distant Recurrence, Biomarker Testing, Clinical Trial vs Standard Treatment, and Questions to Ask Your Doctor.

Where this comes from

Words to know

Tap any term to see what it means.

Browse the full glossary →

An older woman talks with a woman across a table at home

Common questions

What does in-transit disease mean?

Deposits in the skin and the tissue between the original scar and the nearest lymph node basin. It gets a lot of attention in melanoma because this cancer produces the pattern more than most. Ask what you are feeling for along that path.

If a sentinel node is positive, do all the nodes come out?

Not automatically any more. NCI reports a trial in which complete node dissection did not improve distant metastasis-free survival, while lymphedema occurred in 24.1% of the dissection group against 6.3% of the group under observation. NCI describes ultrasound surveillance of the regional nodes as an option instead.

Which drugs are on the list now?

For stage III melanoma that cannot be removed, stage IV, and recurrent melanoma, NCI lists immunotherapy with pembrolizumab, nivolumab, ipilimumab, interleukin-2, nivolumab with relatlimab, or atezolizumab, and targeted therapy with dabrafenib, trametinib, vemurafenib, cobimetinib, encorafenib and binimetinib. That is a catalogue rather than a running order. Interleukin-2 in particular belongs to an earlier era and is now used rarely and only in selected centres. Which of these applies to you depends on your BRAF result, whether you had adjuvant treatment already, how fast the disease is moving and your other health.

Questions to ask your doctor

Being prepared helps you get the most out of your appointments. Save or print these questions.

Open my question list

Tap a question to save it to your list (kept on this device).

Your next step

Turn this topic into questions for your next appointment.

Build a question list
Human Connection Layer

Speak With Trained Specialists & Human Navigators

Cancer Explained provides educational guidance, but does not replace trained specialists, social workers, or your medical team.

Free & Confidential

Talk to a trained cancer information specialist

Free, confidential assistance from NCI Cancer Information Service via phone, chat, or email.

Contact your oncology team

Locate after-hours contact numbers, portal messages, or urgent triage phone lines.

Find a patient navigator

Get one-on-one help with appointments, logistics, translation, and care coordination.

Find a genetic counselor

Discuss inherited mutation risk, family history, and genetic testing options.

Find an oncology social worker

Access emotional counseling, family support groups, and mental health resources.

Find a financial navigator

Locate copay assistance foundations, grant programs, and lodging/travel support.

Find a clinical-trial specialist

Search matching studies and speak with NCI trial information specialists.

Get urgent help

Immediate emergency guidance for fever (>100.4°F during chemo), severe pain, or shortness of breath.

Help Us Improve This Guide

Did this explanation answer your question and help you determine your next step?

Know someone who needs this?

Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.

Email itText itWhatsApp

Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.

Plain-language explanation of the published sources cited on this page. AI-assisted, source-checked, not clinician-reviewed.

Sources last checked: 2026-08-11 what this meansLast updated: 2026-08-19Next planned review: 2028-07-30

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status — Source checked. This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

High-risk topic — talk to your care team. This topic can involve urgent, individual medical decisions. This page is general education only: it cannot tell you whether your situation is an emergency or what you personally should do. Follow your oncology team's instructions and contact them for individual guidance.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Our editorial processHow we use AIReport an error

How this page was created

Cancer Explained does not originate medical claims. Every page restates guidance already published by the National Cancer Institute, the CDC, the USPSTF and the FDA, in plain language, with the source cited so you can check the original yourself. AI does the translating and organizing; automated checks test claims, citations, clarity and safety before anything publishes. We do not employ clinicians and do not intend to — our work is translation and navigation, not clinical judgment. Nothing here is personal medical advice, and no page can account for your particular situation.

Editorial status: Source checked This page was written with AI assistance and checked line by line against the sources listed on it. That confirms the sources support what the page says. It is not a medical review, and it does not confirm the page is complete or right for your situation.

Human medical review: not completed. Pages here are not signed off by a clinician before they publish. That is not an oversight we are quietly working around: we restate published guidance and cite it, so the authority belongs to the source rather than to us, and every page names where its claims come from — you can verify us instead of trusting us. Where a volunteer clinician has reviewed a page, their name and credentials appear on it; where no name appears, no clinician has checked it. We are glad to have reviewers and are recruiting them, and we do not hold pages back waiting for one. Use this site to understand your situation and to ask better questions of the people treating you.

Read more about our editorial process, our use of AI, and our corrections policy.

Spotted a problem? Report an error — a factual mistake, broken or outdated source, confusing wording, or anything that seems unsafe. Please do not include names, medical record numbers, dates of birth, addresses, or other identifying medical information in your report.

After using this page, do you understand what to do next?

Anonymous — we only record the answer, never who gave it.